IRadimed Corp
NASDAQ:IRMD
IRadimed Corp
Revenue
IRadimed Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRadimed Corp
NASDAQ:IRMD
|
Revenue
$65.6m
|
CAGR 3-Years
27%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
IRadimed Corp
Revenue Breakdown
Breakdown by Geography
IRadimed Corp
Total Revenue:
65.6m
USD
|
United States:
52.5m
USD
|
Represents Information Pertaining To Internat...:
13m
USD
|
Breakdown by Segments
IRadimed Corp
See Also
What is IRadimed Corp's Revenue?
Revenue
65.6m
USD
Based on the financial report for Dec 31, 2023, IRadimed Corp's Revenue amounts to 65.6m USD.
What is IRadimed Corp's Revenue growth rate?
Revenue CAGR 10Y
19%
Over the last year, the Revenue growth was 23%. The average annual Revenue growth rates for IRadimed Corp have been 27% over the past three years , 17% over the past five years , and 19% over the past ten years .